Syner-G is proud to participate in the upcoming AI Drug Discovery & Development (AIDDD) Summit, where leading innovators from across the biopharma value chain come together to share real-world lessons on deploying AI to accelerate drug development.
AI is no longer a future initiative. It is already shaping discovery, development, manufacturing, and clinical operations. AIDDD brings together the practitioners who are implementing these technologies today to discuss what is working, where challenges remain, and how organizations can turn AI investments into measurable impact.
Featured Panel
Cross-Functional Lessons to Improve AI Deployment in Process Development and Manufacturing
Jennifer Kilroy, PhD, MBA, SVP, Strategy & Transformation, Syner-G
Day 2 | October 28
11:30 AM – 12:00 PM
TechOps Stage
Join Jennifer and fellow industry leaders as they explore practical, cross-functional approaches to AI deployment in process development and manufacturing, including strategies for driving adoption, overcoming organizational barriers, and delivering sustainable business value.
Whether you’re evaluating AI opportunities, scaling digital transformation initiatives, or looking to accelerate operational performance, we’d welcome the opportunity to connect.
Meet with Jennifer and the Syner-G team to discuss strategies for building value through human-centered AI transformation.
About Jen
Jennifer Kilroy is SVP, Head of Strategy & Transformation at Syner-G, where she partners with pharmaceutical, biotechnology, and medical device organizations to accelerate business performance through strategic transformation, AI adoption, digital innovation, and M&A integration. With more than two decades of experience leading enterprise transformation initiatives, she is recognized for her ability to bridge strategy, technology, and people, advising executive leadership teams on responsibly adopting AI while keeping patient outcomes, workforce readiness, and regulatory expectations front and center.
Jennifer is a passionate advocate for human-centric AI and frequently speaks on its future across research, development, manufacturing, and business operations in life sciences. Through her team’s “3D Intelligence” model, organizations have improved the return on their AI investments by driving workforce adoption, efficiency, and effectiveness. At Syner-G, she leads a multidisciplinary team of consultants in strategy, program management, change management, and organizational development, helping clients navigate digital modernization, portfolio growth, and post-merger integration. Jennifer holds a PhD in Business Management, an Executive MBA, and an MBS in Human Resource Management, and is certified in executive coaching and Lean Six Sigma.
